Brentuximab vedotin
Brentuximab vedotin | |
---|---|
Term | Brentuximab vedotin |
Short definition | brentuximab vedotin - (pronounced) (bren-TUK-sih-mab veh-DOH-tin) medicine used alone or with other medicines to treat adults with certain types of cutaneous or systemic anaplastic large cell lymphoma, peripheral T-cell lymphoma, classic Hodgkin's lymphoma, or mycosis fungoides, and with other medicines to treat children aged 2 years and older used with certain medicines Types of classical Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
brentuximab vedotin - (pronounced) (bren-TUK-sih-mab veh-DOH-tin) medicine used alone or with other medicines to treat adults with certain types of cutaneous or systemic anaplastic large cell lymphoma, peripheral T-cell lymphoma, classic Hodgkin's lymphoma, or mycosis fungoides, and with other medicines to treat children aged 2 years and older used with certain medicines Types of classical Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Brentuximab Vedotin contains a monoclonal antibody that attaches to a protein called CD30 found on some lymphoma cells. It also contains a cancer drug that can help kill cancer cells. Brentuximab vedotin is a type of antibody-drug conjugate. Also called Adcetris and SGN-35
External links
- Medical encyclopedia article on Brentuximab vedotin
- Wikipedia's article - Brentuximab vedotin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski